Cashu
Ascendis Pharma A/S Sees Positive Shift in Short Selling Sentiment and Investor Confidence
3 days ago
Stocks
Health Care
asnd
Ascendis Pharma A/S
ASND
+1.08 (+0.62%)
174.18
USD
At close at Jul 04, 20:40 UTC
Overview
Loading chart...
Key Stats
Market Cap
10.02B
Dividend Yield
0.00%
P/E Ratio
-22.52
EPS
-7.13
Revenue
388.36M
Avg. Volume
622.28K
About
What does ASND do?
Ascendis Pharma A/S is a global biopharmaceutical company developing drug candidates for growth hormone deficiency, endocrinology, CNS disorders, infectious diseases, and diabetes. It operates through multiple subsidiaries in Germany and Denmark.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.